Inotuzumab ozogamicin as a single agent to treat T315I-mutated chronic myeloid leukemia with acute blastic change to CD22+ acute lymphocytic leukemia
oleh: Pei-Ying Hsieh, Shang-Ju Wu, Che-Pin Lin
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2023-03-01 |
Deskripsi
No description available for this item.